Jay D. Kranzler - Sep 27, 2024 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
Director
Signature
/s/ David Jin, Attorney-in-Fact
Stock symbol
ATXI
Transactions as of
Sep 27, 2024
Transactions value $
$1,250
Form type
4
Date filed
10/1/2024, 04:15 PM
Previous filing
Sep 25, 2024
Next filing
Nov 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATXI COMMON STOCK, PAR VALUE $0.0001 Purchase $7.20 +3 +2.5% $2.40 123 Sep 27, 2024 Direct F1
transaction ATXI COMMON STOCK, PAR VALUE $0.0001 Purchase $1.24K +497 +404.07% $2.50 620 Sep 30, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the "Reverse Stock Split") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.